BIOSAPIEN
BioSapien is a pre-clinical biotech company developing novel biodegradable implantable products that deliver active pharmaceutical ingredients (APIs) for oncology indications with reduced systemic side effects. The applications for this technology are currently under investigation for pancreatic cancer and lung cancer. The intended pipeline of indications is expected to expand into other cancers such as colorectal, breast, and stomach cancers. BioSapien's 3D-printed MediChip delivers FDA-approved toxic high-dose systemic therapies in a localized slow-release biodegradable mesh which is able to target tissues while improving patients' quality of care and life.
BIOSAPIEN
Social Links:
Industry:
3D Printing 3D Technology Biopharma Biotechnology Pharmaceutical
Founded:
2018-06-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.biosapien.com
Total Employee:
1+
Status:
Active
Contact:
917-647-8600
Email Addresses:
[email protected]
Total Funding:
2.06 M USD
Technology used in webpage:
Twitter Timeline InMotion Hosting InMotion Hosting DNS
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Castle Creek Biosciences
Castle Creek Biosciences is focused on developing commercializing novel, personalized gene therapies for rare skin disorders.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Eidos Therapeutics
Eidos Therapeutics is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Current Advisors List
Current Employees Featured
Founder
Investors List
National Science Foundation
National Science Foundation investment in Grant - BioSapien
Infinity Capital
Infinity Capital investment in Seed Round - BioSapien
MicroVentures
MicroVentures investment in Seed Round - BioSapien
Kartik Garg
Kartik Garg investment in Seed Round - BioSapien
Hikma Ventures
Hikma Ventures investment in Seed Round - BioSapien
Harbr
Harbr investment in Seed Round - BioSapien
SOSV
SOSV investment in Seed Round - BioSapien
Beni VC
Beni VC investment in Seed Round - BioSapien
George and Saul
George and Saul investment in Seed Round - BioSapien
Side Door Ventures
Side Door Ventures investment in Seed Round - BioSapien
Official Site Inspections
http://www.biosapien.com
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
